A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes.
about
A Bayesian adaptive Phase I-II clinical trial for evaluating efficacy and toxicity with delayed outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@en
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@nl
type
label
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@en
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@nl
prefLabel
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@en
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@nl
P2860
P356
P1433
P1476
A Bayesian adaptive Phase I-II ...... oxicity with delayed outcomes.
@en
P2093
Joseph S Koopmeiners
P2860
P356
10.1177/1740774513500589
P577
2013-09-30T00:00:00Z